Aziz NAAM - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations.

Aziz NAAM, George RF, El-Adl K, Mahmoud WR. Aziz NAAM, et al. Arch Pharm (Weinheim). 2023 Mar;356(3):e2200465. doi: 10.1002/ardp.202200465. Epub 2022 Nov 20. Arch Pharm (Weinheim). 2023. PMID: 36403198

Design, synthesis, in silico docking, ADMET and anticancer evaluations of thiazolidine-2,4-diones bearing heterocyclic rings as dual VEGFR-2/EGFR^T790M tyrosine kinase inhibitors.

Aziz NAAM, George RF, El-Adl K, Mahmoud WR. Aziz NAAM, et al. RSC Adv. 2022 Apr 27;12(20):12913-12931. doi: 10.1039/d2ra01119k. eCollection 2022 Apr 22. RSC Adv. 2022. PMID: 35496328 Free PMC article.

Design, synthesis, and docking of novel thiazolidine-2,4-dione multitarget scaffold as new approach for cancer treatment.

Hanafy NS, Aziz NAAM, El-Hddad SSA, Abdelgawad MA, Ghoneim MM, Dawood AF, Mohamady S, El-Adl K, Ahmed S. Hanafy NS, et al. Among authors: aziz naam. Arch Pharm (Weinheim). 2023 Jul;356(7):e2300137. doi: 10.1002/ardp.202300137. Epub 2023 May 5. Arch Pharm (Weinheim). 2023. PMID: 37147779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters